Protriptyline Hydrochloride



Protriptyline Hydrochloride





(proe trip’ ti leen)

Vivactil

PREGNANCY CATEGORY C


Drug Class

TCA (secondary amine)


Therapeutic Actions

Mechanism of action unknown; the TCAs are structurally related to the phenothiazine antipsychotic drugs (eg, chlorpromazine), but in contrast to the phenothiazines, TCAs inhibit the presynaptic reuptake of the neurotransmitters norepinephrine and serotonin; anticholinergic at CNS and peripheral receptors; the relation of these effects to clinical efficacy is unknown.


Indications



  • Relief of symptoms of depression (endogenous depression most responsive; unlike other TCAs, protriptyline is “activating” and may be useful in withdrawn and anergic patients)


  • Unlabeled uses: Treatment of obstructive sleep apnea, prevention of migraine



Available Forms

Tablets—5, 10 mg


Dosages

Adults

15–40 mg/day PO in three to four divided doses initially. May gradually increase to 60 mg/day if necessary. Do not exceed 60 mg/day. Make increases in dosage in the morning dose.

Pediatric patients

Not recommended; may increase risk of suicidal ideation.

Geriatric patients and adolescents

Initially, 5 mg tid PO. Increase gradually if needed. Monitor CV system closely if dose exceeds 20 mg/day.

Jul 21, 2016 | Posted by in NURSING | Comments Off on Protriptyline Hydrochloride

Full access? Get Clinical Tree

Get Clinical Tree app for offline access